[go: up one dir, main page]

ZA200108735B - Renin inhibitors. - Google Patents

Renin inhibitors.

Info

Publication number
ZA200108735B
ZA200108735B ZA200108735A ZA200108735A ZA200108735B ZA 200108735 B ZA200108735 B ZA 200108735B ZA 200108735 A ZA200108735 A ZA 200108735A ZA 200108735 A ZA200108735 A ZA 200108735A ZA 200108735 B ZA200108735 B ZA 200108735B
Authority
ZA
South Africa
Prior art keywords
renin inhibitors
renin
inhibitors
Prior art date
Application number
ZA200108735A
Other languages
English (en)
Inventor
Volker Breu
Eric Vieira
Hans-Peter Maerki
Wolfgang Wostl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200108735B publication Critical patent/ZA200108735B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
ZA200108735A 1999-04-27 2001-10-23 Renin inhibitors. ZA200108735B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108199 1999-04-27

Publications (1)

Publication Number Publication Date
ZA200108735B true ZA200108735B (en) 2003-01-23

Family

ID=8238050

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108735A ZA200108735B (en) 1999-04-27 2001-10-23 Renin inhibitors.

Country Status (35)

Country Link
US (2) US6376672B1 (fr)
EP (1) EP1175400B1 (fr)
JP (1) JP3808706B2 (fr)
KR (1) KR100443684B1 (fr)
CN (1) CN1147471C (fr)
AR (2) AR018719A1 (fr)
AT (1) ATE512949T1 (fr)
AU (1) AU763718B2 (fr)
BR (1) BR0010080B1 (fr)
CA (1) CA2370888C (fr)
CO (1) CO5170513A1 (fr)
CZ (1) CZ302012B6 (fr)
DK (1) DK1175400T3 (fr)
EG (1) EG23979A (fr)
ES (1) ES2366668T3 (fr)
GC (1) GC0000251A (fr)
HK (1) HK1045999B (fr)
HR (1) HRP20010762A2 (fr)
HU (1) HU227764B1 (fr)
IL (2) IL146002A0 (fr)
JO (1) JO2256B1 (fr)
MA (1) MA26787A1 (fr)
MX (1) MXPA01010934A (fr)
MY (1) MY127894A (fr)
NO (1) NO320803B1 (fr)
NZ (1) NZ514981A (fr)
PE (1) PE20010069A1 (fr)
PL (1) PL199895B1 (fr)
PT (1) PT1175400E (fr)
RS (1) RS51156B (fr)
RU (1) RU2213731C2 (fr)
TR (1) TR200103095T2 (fr)
TW (1) TWI224593B (fr)
WO (1) WO2000064873A1 (fr)
ZA (1) ZA200108735B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6835686B2 (en) * 2001-07-05 2004-12-28 Millennium Specialty Chemicals Catalyst system and process for rearrangement of epoxides to allylic alcohols
PL375214A1 (en) * 2002-06-27 2005-11-28 Actelion Pharmaceuticals Ltd. Novel tetrahydropyridine derivatives as renin inhibitors
US20040214832A1 (en) * 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors
EP1620403B1 (fr) * 2003-04-29 2007-11-28 Actelion Pharmaceuticals Ltd. Nouveaux derives de la 1,2,3,6-tetrahydropyridine 3,4-disubstituee
TW200900399A (en) * 2003-10-01 2009-01-01 Speedel Experimenta Ag Organic compounds
AR045950A1 (es) * 2003-10-09 2005-11-16 Speedel Experimenta Ag Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
US20070078164A1 (en) * 2003-11-26 2007-04-05 Richard Sedrani 4-Phenylpiperidine derivatives as renin inhibitors
TW200613274A (en) * 2004-07-09 2006-05-01 Speedel Experimenta Ag Organic compounds
BRPI0516128A (pt) 2004-10-08 2008-08-26 Novartis Ag uso de inibidores de renina para a prevenção ou tratamento de disfunção diastólica ou insuficiência cardìca diastólica
GB0428526D0 (en) * 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
TW200716622A (en) * 2005-03-31 2007-05-01 Speedel Experimenta Ag Substituted piperidines
CN101151262B (zh) * 2005-03-31 2011-07-06 斯皮德尔实验股份公司 取代的哌啶
AR053836A1 (es) * 2005-03-31 2007-05-23 Speedel Experimenta Ag Piperdinas 3,4,5-sustituidas
EP1897879A3 (fr) * 2005-03-31 2008-06-11 Speedel Experimenta AG Pipéridines 2,4,5-substituées comme inhibiteurs de la rénine
EP1707202A1 (fr) * 2005-03-31 2006-10-04 Speedel Experimenta AG Composes organiques
TW200722424A (en) * 2005-03-31 2007-06-16 Speedel Experimenta Ag Substituted piperidines
AU2006253805A1 (en) 2005-05-27 2006-12-07 Actelion Pharmaceuticals Ltd. Novel piperidine carboxylic acid amide derivatives
GB0514203D0 (en) * 2005-07-11 2005-08-17 Novartis Ag Organic compounds
US20080255084A1 (en) * 2005-10-21 2008-10-16 Randy Lee Webb Combination of Organic Compounds
CN101356156B (zh) * 2005-11-14 2012-12-05 生命医药公司 天冬氨酸蛋白酶抑制剂
JP5306821B2 (ja) * 2005-12-30 2013-10-02 ノバルティス アーゲー レニン阻害剤としての３，５−置換ピペリジン化合物
TW200804359A (en) 2006-01-19 2008-01-16 Speedel Experimenta Ag Substituted 4-phenylpiperidines
EP1816122A3 (fr) * 2006-01-19 2007-09-19 Speedel Experimenta AG Pipéridines substituées 3,4,5 en tant que composants thérapeutiques
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
WO2008021552A2 (fr) * 2006-08-18 2008-02-21 Duke University Ligands biaisés et leurs procédés d'identification
EP1911758A1 (fr) * 2006-10-04 2008-04-16 Speedel Experimenta AG Derivés de phenyl-piperidine comme inhibiteurs de renin
EP1908761A1 (fr) * 2006-10-04 2008-04-09 Speedel Experimenta AG Composés organiques
EP2527338B1 (fr) 2007-06-25 2015-05-06 Novartis AG Dérivés de n5-(2-éthoxyéthyl)-n3-(2-pyridinyl) -3,5-pipéridinedicarboxamide en tant qu'inhibiteurs de la rénine
BRPI0819352A2 (pt) * 2007-11-02 2015-04-22 Novartis Ag Piperidinas 4,4-dissubstituídas
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
AU2010305901A1 (en) 2009-10-14 2012-05-24 Rainer Oberbauer Acute kidney injury risk testing
WO2013045505A1 (fr) 2011-09-28 2013-04-04 Novartis Ag Biomarqueurs pour traitement combiné par des agents sraa
EP2810644A1 (fr) 2013-06-06 2014-12-10 Ferrer Internacional, S.A. Formulation orale pour le traitement de maladies cardiovasculaires
WO2018002673A1 (fr) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Nouvelles formulations d'antagonistes du récepteur de l'angiotensine ii

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
DK231088D0 (da) 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
DE3640475A1 (de) 1986-11-27 1988-06-09 Hoechst Sa Lab Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung
CA2114013A1 (fr) 1991-06-24 1993-01-07 John Van Groningen Dispositif de mesure de la frequence respiratoire d'une personne
WO1997003911A1 (fr) 1995-07-24 1997-02-06 Railfix N.V. L'invention concerne un dispositif permettant de man×uvrer une charge magnetique, notamment ferromagnetique
IL123293A (en) * 1995-09-07 2003-06-24 Hoffmann La Roche Piperidine derivatives, their preparation and pharmaceutical compositions containing them
AU9740998A (en) * 1997-09-08 1999-03-29 F. Hoffmann-La Roche Ag Piperidine derivatives against malaria
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors

Also Published As

Publication number Publication date
AU4296800A (en) 2000-11-10
CA2370888A1 (fr) 2000-11-02
HRP20010762A2 (en) 2005-02-28
RU2213731C2 (ru) 2003-10-10
CZ20013854A3 (cs) 2002-04-17
CN1147471C (zh) 2004-04-28
NO320803B1 (no) 2006-01-30
PE20010069A1 (es) 2001-03-03
HUP0203669A3 (en) 2003-12-29
BR0010080A (pt) 2002-01-15
HK1045999A1 (en) 2002-12-20
MA26787A1 (fr) 2004-12-20
CO5170513A1 (es) 2002-06-27
TR200103095T2 (tr) 2002-04-22
JP3808706B2 (ja) 2006-08-16
CN1349503A (zh) 2002-05-15
KR100443684B1 (ko) 2004-08-09
AR018719A1 (es) 2001-11-28
US6376672B1 (en) 2002-04-23
IL146002A0 (en) 2002-07-25
ATE512949T1 (de) 2011-07-15
GC0000251A (en) 2006-11-01
MY127894A (en) 2006-12-29
AR070473A2 (es) 2010-04-07
NO20015206D0 (no) 2001-10-25
YU77101A (sh) 2004-09-03
NZ514981A (en) 2004-02-27
US20020087002A1 (en) 2002-07-04
BR0010080B1 (pt) 2012-03-20
US6673931B2 (en) 2004-01-06
RS51156B (sr) 2010-10-31
NO20015206L (no) 2001-10-25
JP2002543063A (ja) 2002-12-17
PT1175400E (pt) 2011-08-11
ES2366668T3 (es) 2011-10-24
WO2000064873A1 (fr) 2000-11-02
HUP0203669A2 (hu) 2003-02-28
DK1175400T3 (da) 2011-07-18
AU763718B2 (en) 2003-07-31
EP1175400A1 (fr) 2002-01-30
PL199895B1 (pl) 2008-11-28
EG23979A (en) 2008-02-27
HU227764B1 (en) 2012-02-28
KR20010109529A (ko) 2001-12-10
MXPA01010934A (es) 2002-05-06
PL353442A1 (en) 2003-11-17
EP1175400B1 (fr) 2011-06-15
TWI224593B (en) 2004-12-01
JO2256B1 (en) 2004-10-07
IL146002A (en) 2007-03-08
HK1045999B (zh) 2004-10-21
CZ302012B6 (cs) 2010-09-08
CA2370888C (fr) 2005-08-23

Similar Documents

Publication Publication Date Title
ZA200108735B (en) Renin inhibitors.
GB9900416D0 (en) Inhibitors
ZA200109890B (en) Metalloprotease inhibitors.
MXPA03005838A (es) Inhibidores de antigenos de aparicion muy tardia-4.
PL362903A1 (en) Renin inhibitors
IL148820A0 (en) Fab i inhibitors
ZA200108016B (en) Pyrazolobenzodiazephines as CDK2 inhibitors.
MXPA01013406A (es) Compuestos inhibidores de vla-4.
MXPA02005067A (es) Composicion inhibidora de la corrosion.
ZA200110053B (en) Factor via inhibitors.
EP1235577A4 (fr) Inhibiteurs de protease
EP1153022A4 (fr) Inhibiteurs de protease
GB9924522D0 (en) Enzyme inhibitors
EP1232155A4 (fr) Inhibiteurs de protease
ZA200007405B (en) Angiogenesis inhibitors.
EP1229912A4 (fr) Inhibiteurs de protease
EP1229914A4 (fr) Inhibiteurs de protease
EP1231921A4 (fr) Inhibiteurs de proteases
EP1229915A4 (fr) Inhibiteurs de protease
EP1233771A4 (fr) Inhibiteurs de protease
EP1351930A4 (fr) Inhibiteurs de la protease
EP1173429A4 (fr) Inhibiteurs de protease
EP1161237A4 (fr) Inhibiteurs de protease
EP1229911A4 (fr) Inhibiteurs de proteases
EP1231923A4 (fr) Inhibiteurs de protease